Comments on the article “Changes in hypertensive control 2020-2021 in a family medicine unit”
Main Article Content
Keywords
High Blood Pressure, Antihypertensive Agent, COVID-19 Pandemic, Risk Factors, Primary Health Care
Abstract
The objective of this letter to the editor is to emphasize about the control of chronic diseases, especially hypertension during the COVID-19 pandemic, as well as to comment some aspects about the research done in a primary care unit, specifically about the factors that could contribute on the poor hypertensive control, some of them commented on the article but others not completely clarified.
References
Tetetla-Castro D, Cruz-Martín GJ, Castro-Ríos A. Cambios en el control hipertensivo 2020-2021 en una unidad de medicina familiar. Rev Med Inst Mex Seguro Soc. 2024;62(4):e6053. doi: 10.5281/zenodo.11397116.
Jamison DA Jr, Anand Narayanan S, Trovão NS, et al. A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection. Eur J Hum Genet. 2022;30(8):889-98. doi: 10.1038/s41431-022-01108-8
Hacker KA, Briss PA, Richardson L, et al. COVID-19 and Chronic Disease: The Impact Now and in the Future. Prev Chronic Dis. 2021;18:210086. doi: 10.5888/pcd18.210086
Gaya PV, Fonseca GWP, Tanji LT, et al. Smoking cessation decreases arterial blood pressure in hypertensive smokers: A subgroup analysis of the randomized controlled trial GENTSMOKING. Tob Induc Dis. 2024;22. doi: 10.18332/tid/186853
Narayanan SA, Jamison DA Jr, Guarnieri JW, et al. A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection. Eur J Hum Genet. 2024 Jan;32(1):10-20. doi: 10.1038/s41431-023-01462-1
Stachteas P, Symvoulakis M, Tsapas A, et al. The impact of the COVID-19 pandemic on the management of patients with chronic diseases in Primary Health Care. Population Medicine. 2022;4:23. doi: 10.18332/popmed/152606
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.